http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009137844-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d55885fb3d9777b1006cefa3af8cee2f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 |
| filingDate | 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7977143db705f63b1404bde0b9b39ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78253d180c0decbe5d5ec8f3a2291412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ecd36011bb54115074529c24399fc25 |
| publicationDate | 2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009137844-A |
| titleOfInvention | Blood uric acid level lowering agent |
| abstract | An object of the present invention is to develop a new system that is effective for the prevention and / or improvement of hyperuricemia and gout, which has no risk of side effects even after long-term ingestion and is effective and highly safe. It is what. The above problems have been solved by an agent containing at least one of uridylic acid, uridine, and uracil as an active ingredient. Uridilic acid, etc. was newly found to have an action of lowering blood uric acid level by administering this, and by administering uridylic acid, etc., hyperuricemia, gout, urinary calculus, It enables prevention and / or treatment of renal dysfunction and the like. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018095590-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6860245-B1 |
| priorityDate | 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.